Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib Combined With FOLFOX/FOLFIRI in Advanced Colorectal Liver Metastases
NCT07441369Phase 2Enrolling by invitation
- Sponsor
- Fudan University
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in colorectal cancer (CRC), sponsored by Fudan University. Started Jul 2026; status: enrolling by invitation.
02
Drugs
abemaciclib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07441369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07441369.